Cite
HARVARD Citation
Turner, D. et al. (n.d.). DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn's disease: interim results of the CAPE registry. Journal of Crohn's and colitis. p. S035. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Turner, D. et al. (n.d.). DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn's disease: interim results of the CAPE registry. Journal of Crohn's and colitis. p. S035. [Online].